Table 1.

Clinical information on a human SLE cohort (n = 41).

	Mean ± S.D.	Median (Min-Max)
Age	39 ± 12 years	44 (20–68)
Sex Female: Male	39 : 2
SLEDAI	4.7 ± 4.2	4 (0–18)
Organ Involvement
Skin Involvement	5
Arthritis	14
Kidney	4
Lupus Headache	1
Low Complement	3
Mucosal Ulcers	1
Vasculitis	2
Unknown	1
Lab Work	[Ref. Range]
Serum Creatinine mg/dL	0.7 ± 0.2 [0.59–1.04]	0.6 (0.5–1.3)
Serum Protein g/dL	7.1 ±0.7 [[6], [7], [8]]	7.1 (5.9–8.9)
Urine Creatinine	61.9 ± 42.5	46 (20.4–122.1)
C3 mg/dL	102.4 ± 36.3 [80–160]	97 (42–179.7)
C4 mg/dL	22.2 ± 12 [[15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42], [43], [44], [45]]	18 (5–60)
ESR mm/hr	34.2 ± 21.5 [0–29]	29 (3–72)
CRP mg/dL	4 ± 4.2 [<1]*	1 (0.3–15.5)
Medications
Antimalarials	58%
Steroids (2.5–20 mg)	58%
Immunosuppressants	33%